Elicio Therapeutics Inc.
About
Elicio Therapeutics Inc. (NASDAQ:ELTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Feb 25 2026
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Jan 16 2026
Elicio Therapeutics Reports Inducement Grants
Dec 11 2025
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
Nov 19 2025
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
Recent Videos
Elicio Therapeutics: My Critical Take on Their "Going Concern" Warning
Mar 17, 2026
FluoroSpot in clinical trials: measuring antigens specific cell responses at a single cells level
Mar 11, 2026
Windfluencer - Elicio
Mar 10, 2026
POTENTIAL EXPANSION : ELTX STOCK ANALYSIS | ELICIO THERAPEUTICS STOCK
Oct 01, 2025
Financials
Revenue
$0
Market Cap
$196.29 M
EPS
-2.58